Insider Holders & Insider Ownership - ANGIODYNAMICS INC (ANGO)

List of insiders holdings for ANGIODYNAMICS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
EZ EM INC
10% Owner		2004-10-12 13:17:079,200,000
0		9,200,000Form 4
STERN HOWARD S
Director
10% Owner		2005-12-29 10:00:061,749,584
0		1,749,584Form 4
Estate of Howard S. Stern
10% Owner		2007-06-28 15:08:411,324,685
0		1,324,685Form 13D
Stern Linda B
10% Owner		2008-12-23 16:03:09675,812
0		675,812Form 13D
Clemmer James C
President and CEO		2024-04-08 16:30:17539,066
0		539,066Form 4
HOBBS EAMONN P
President & CEO		2009-02-17 17:50:01451,651
0		451,651Form 4
Burgstahler David F
Director
10% Owner		2017-04-14 16:48:3723,988
381,406		405,394Form 4
MEYERS DAVID P
Director		2006-08-17 09:12:40390,187
0		390,187Form 4
DEVIVO JOSEPH
President and CEO		2015-09-11 20:36:57198,451
0		198,451Form 4
ECHENBERG PAUL S
Director Emeritus		2012-04-27 19:15:50154,412
0		154,412Form 4
BUCCI VINCENT
Director		2013-10-25 10:54:5188,312
55,000		143,312Form 4
Meteny Dennis S
Director		2023-07-21 21:11:16140,019
0		140,019Form 4
GRAHAM PETER J
Director		2006-10-27 10:02:4862,882
66,227		129,109Form 4
Trowbridge Stephen A
EVP and CFO		2024-03-04 20:49:30128,901
0		128,901Form 4
DONNELLY HOWARD W
Director		2023-07-21 21:11:11128,835
0		128,835Form 4
Keltjens Jan
President & CEO		2011-01-21 12:29:25109,276
0		109,276Form 4
JOHNSON WESLEY
Director		2023-07-21 21:11:13105,322
0		105,322Form 4
GOLD JEFFREY
Director		2019-07-19 21:20:0083,640
0		83,640Form 4
Gould Kevin J
Director		2020-07-16 19:06:2877,504
0		77,504Form 4
ROSSELL ROBERT M
VP - Marketing		2009-10-13 17:42:4767,995
0		67,995Form 4
REED JAN STERN
Director		2023-07-21 21:11:0866,818
0		66,818Form 4
Auen Eileen O'Shea
Director		2023-07-21 21:11:0566,502
0		66,502Form 4
Mitchell Robert D
Executive VP and COO		2007-08-20 19:37:5463,542
0		63,542Form 4
Centea Scott
SVP/GM, VIT		2023-09-21 21:17:2362,951
0		62,951Form 4/A
Nighan Warren JR
SVP Quality and Regulatory		2022-07-22 18:42:1454,498
0		54,498Form 4
Campbell Chad Thomas
SVP/GM, Vascular Access		2023-09-21 21:12:2653,016
0		53,016Form 4/A
Licitra Karen A
Director		2023-07-21 21:11:0052,219
0		52,219Form 4
FLAHERTY ROBERT E
Director		2008-08-08 16:41:2950,200
0		50,200Form 4
Wallace Lynda M.
SVP - Business Development		2010-05-19 14:52:3550,000
0		50,000Form 4
LaPorte Steve
Director		2018-07-20 21:27:3448,484
0		48,484Form 4
GERSUK D JOSEPH
EVP - CFO		2012-09-11 18:57:2947,275
0		47,275Form 4
Tarnoff Michael E
Director		2023-07-21 21:11:0345,162
0		45,162Form 4
RECINELLA DANIEL
VP - Product Development		2007-08-20 19:33:3741,174
0		41,174Form 4
McDonald David
SVP - Business Development		2009-02-04 14:33:5640,800
0		40,800Form 3
Morris Sean
SVP - General Manager		2009-02-11 16:02:3940,253
0		40,253Form 3
Frost Mark T
EVP and CFO		2015-08-07 16:44:0338,389
0		38,389Form 4
Casciaro Gregory D
Director		2006-08-17 09:11:0137,500
0		37,500Form 4
PANZER ALAN
SVP, GM - Vascular		2012-08-21 18:33:2237,500
0		37,500Form 4
KUNST BRIAN
VP - Regulatory Affairs		2007-08-20 19:29:5936,780
0		36,780Form 4
Helsel Dave
SVP Global Operations and R&D		2023-09-21 21:23:5734,462
0		34,462Form 4/A
GERARDI JOSEPH G
Vice President		2007-08-20 19:26:1132,992
0		32,992Form 4
Kapusta Matthew C
SVP, Business Development		2014-11-19 16:08:2530,062
0		30,062Form 4
Simpson Robert Arthur
SVP/GM, Global Vascular		2019-08-19 22:00:0225,883
0		25,883Form 4
Bourne George W. IV
CTO and COO		2014-08-08 21:45:4023,613
0		23,613Form 4
APPLING WILLIAM M
Vice-President - Research		2010-09-07 17:56:3223,386
0		23,386Form 4
SOTO JOHN
SVP and CCO		2015-09-11 20:39:0322,452
0		22,452Form 4
Etlinger Richard Scott
SVP - Global Operations		2012-08-21 18:29:0321,957
0		21,957Form 4
Greiner Charles R
VP - Global Franchise		2016-05-09 16:05:3720,910
0		20,910Form 4
Richard Stark
SVP, GM - Oncology		2017-11-17 16:08:3620,754
0		20,754Form 4
McGill Stephen
SVP, GM - International		2014-01-30 14:01:3520,715
0		20,715Form 4
Solano Scott J.
Interim CEO		2011-08-05 20:12:4619,445
0		19,445Form 4
Piccinini Laura
SVP International		2023-07-25 19:06:5619,093
0		19,093Form 4
MAPES HAROLD
VP - Operations		2010-09-07 17:43:4718,684
0		18,684Form 4
Burgess Lorinda
Director		2023-07-21 20:06:2817,041
0		17,041Form 4
ROSENZWEIG RICHARD C
SVP and General Counsel		2023-02-07 16:00:5215,730
0		15,730Form 4
Boucher Brent J.
SVP and GM of Oncology		2020-02-18 19:03:1615,416
0		15,416Form 4
Greiner Michael
EVP and CFO		2019-10-18 18:33:2015,320
0		15,320Form 4
Orsatti Charles Thomas
Director		2011-08-05 20:13:1714,000
0		14,000Form 4
McCarthy Shawn P
SVP - General Manager		2010-08-30 17:27:0910,392
0		10,392Form 4/A
Shea Paul J
VP - Sales		2007-08-10 15:36:395112
0		5112Form 4
Venkataraman Sriram
Director		2016-08-05 16:39:030
0		0Form 4
Avista Capital Partners GP LLC
Avista Capital Partners L.P.
Avista Capital Partners (Offshore) L.P.
Navilyst Medical Co-Invest LLC
10% Owner		2017-04-28 17:26:560
0		0Form 13D